Literature DB >> 24531817

The outcome of urine culture positive and culture negative staghorn calculi after minimally invasive percutaneous nephrolithotomy.

Ming Lei1, Wei Zhu, Shaw P Wan, Yongda Liu, Guohua Zeng, Jian Yuan.   

Abstract

The purpose of this study was to compare the treatment outcomes of staghorn stones using minimally invasive percutaneous nephrolithotomy (MPCNL) in patients who had positive preoperative urine culture to patients with negative urine culture. The records of 284 patients with staghorn calculi, who underwent MPCNL in our center from January 2012 to January 2013, were retrospectively analyzed. Patients were divided into positive and negative group, according to the result of preoperative urine culture. Staghorn stones with negative culture received a single dose of broad spectrum antibiotic prophylaxis, whereas stones with positive culture were treated for at least 72 h according to antibiogram. The perioperative findings and postoperative outcomes were compared between the two groups. There were 70 (24.6%) patients with positive and 214 (75.4%) patients with negative preoperative urine culture who underwent MPCNL. There were no statistical differences in the duration of hospital stay, operative time, estimated blood loss, final stone free rate (SFR) as well as the incidence of the following infectious complications such as fever, systemic inflammatory response syndrome and septic shock, between both groups. Our retrospective study showed that MPCNL was a safe and effective modality in the treatment of staghorn stones. The morbidity, complication, and SFR were similar between patients with positive and negative preoperative urine cultures, once the culture positive infections were adequately controlled.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531817     DOI: 10.1007/s00240-014-0645-4

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  16 in total

Review 1.  Pathophysiology and management of infectious staghorn calculi.

Authors:  Kelly A Healy; Kenneth Ogan
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

2.  The percutaneous nephrolithotomy global study: classification of complications.

Authors:  Gaston Labate; Pranjal Modi; Anthony Timoney; Luigi Cormio; Xiaochun Zhang; Michael Louie; Magnus Grabe; Jean Rosette On Behalf Of The Croes Pcnl Study Group
Journal:  J Endourol       Date:  2011-07-13       Impact factor: 2.942

3.  Changing composition of staghorn calculi.

Authors:  Davis P Viprakasit; Mark D Sawyer; S Duke Herrell; Nicole L Miller
Journal:  J Urol       Date:  2011-10-20       Impact factor: 7.450

Review 4.  Therapeutic challenges of urosepsis.

Authors:  F M E Wagenlehner; A Pilatz; K G Naber; W Weidner
Journal:  Eur J Clin Invest       Date:  2008-10       Impact factor: 4.686

5.  Prevention and treatment of septic shock following mini-percutaneous nephrolithotomy: a single-center retrospective study of 834 cases.

Authors:  Chunlai Liu; Xiling Zhang; Yili Liu; Ping Wang
Journal:  World J Urol       Date:  2012-12-18       Impact factor: 4.226

6.  Treatment of upper urinary calculi with Chinese minimally invasive percutaneous nephrolithotomy: a single-center experience with 12,482 consecutive patients over 20 years.

Authors:  Guohua Zeng; Zanlin Mai; Zhijian Zhao; Xun Li; Wen Zhong; Jian Yuan; Kaijun Wu; Wenqi Wu
Journal:  Urolithiasis       Date:  2013-04-25       Impact factor: 3.436

7.  Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy.

Authors:  B Lojanapiwat; P Kitirattrakarn
Journal:  Urol Int       Date:  2011-04-20       Impact factor: 2.089

8.  The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones.

Authors:  Mahesh Desai; Antonello De Lisa; Burak Turna; Jorge Rioja; Helena Walfridsson; Alessandro D'Addessi; Carson Wong; Jean Rosette On Behalf Of The Croes Pcnl Study Group
Journal:  J Endourol       Date:  2011-07-20       Impact factor: 2.942

9.  Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy.

Authors:  Hasan Serkan Dogan; Fuad Guliyev; Yesim S Cetinkaya; Mustafa Sofikerim; Ender Ozden; Ahmet Sahin
Journal:  Int Urol Nephrol       Date:  2007-02-10       Impact factor: 2.370

10.  Percutaneous nephrolithotomy for staghorn calculi: a single center's experience over 15 years.

Authors:  Frédéric Soucy; Raymond Ko; Mordechai Duvdevani; Linda Nott; John D Denstedt; Hassan Razvi
Journal:  J Endourol       Date:  2009-10       Impact factor: 2.942

View more
  5 in total

1.  How safe is bladder urine culture for the management of percutaneous procedures?

Authors:  Tevfik Ziypak; Senol Adanur
Journal:  Urolithiasis       Date:  2014-03-29       Impact factor: 3.436

2.  Stone culture retrieved during percutaneous nephrolithotomy: is it clinically relevant?

Authors:  Yasser Osman; Ahmed M Elshal; Mohamed M Elawdy; Helmy Omar; Asaad Gaber; Essam Elsawy; Ahmed R El-Nahas
Journal:  Urolithiasis       Date:  2016-01-18       Impact factor: 3.436

3.  The comparison of minimally invasive percutaneous nephrolithotomy and retrograde intrarenal surgery for stones larger than 2 cm in patients with a solitary kidney: a matched-pair analysis.

Authors:  Guohua Zeng; Wei Zhu; Jiasheng Li; Zhijian Zhao; Tao Zeng; Chenli Liu; Yang Liu; Jian Yuan; Shaw P Wan
Journal:  World J Urol       Date:  2014-10-21       Impact factor: 4.226

4.  Mini-nephroscope combined with pressure suction: an effective tool in MPCNL for intrarenal stones in patients with urinary tract infections.

Authors:  Guibin Xu; Yongzhong He; Haibo Zhao; Xianhan Jiang; Gang Feng; Weiqing Yang; Wei Xu; Qingling Xie; Xun Li
Journal:  Urolithiasis       Date:  2016-02-09       Impact factor: 3.436

5.  Perioperative and long-term results of retroperitoneal laparoscopic pyelolithotomy versus percutaneous nephrolithotomy for staghorn calculi: a single-center randomized controlled trial.

Authors:  Ya Xiao; Qianwei Li; Chibing Huang; Pingxian Wang; Jiaxi Zhang; Weihua Fu
Journal:  World J Urol       Date:  2018-10-25       Impact factor: 4.226

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.